This study is currently not recruiting participants.

Stiripentol (Diacomit?) for treatment of Dravet Syndrome in a Single Subject

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to provide the subject with an anti-epileptic drug that may help her with her ongoing atonic seizures.

Detailed description of study

The purpose of this study is to provide the subject with an anti-epileptic drug that may help her with her ongoing atonic seizures.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 100 years or below
  • Gender: All
Updated on 10 Dec 2014. Study ID: 1411789872

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team